Want to keep learning?

This content is taken from the University of Birmingham's online course, Cancer Immunotherapy: a Step Change in Cancer Treatment. Join the course to learn more.
Lung cancer

Patient impact: a lung cancer patient's story

In the downloadable file at the bottom of this step, a lung cancer patient explains the impact of anti-PD-1 therapy on her disease.

This is an excerpt from a statement given by a patient who underwent checkpoint blocakde (anti-PD-1) therapy at the Queen Elizabeth Hospital Birmingham, under the care of Prof Gary Middleton. Since this statement was given, a subsequent scan has confirmed that the patient is still in complete remission.

Share this article:

This article is from the free online course:

Cancer Immunotherapy: a Step Change in Cancer Treatment

University of Birmingham